A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines

Fátima Reyes*, Oscar Otero, Frank Camacho, Nevis Amin, Fidel Ramirez Bencomo, Yolanda Valdés, Reynaldo Acevedo, Luis García, Daniel Cardoso, Maribel Cuello

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

A novel murine hybridoma monoclonal antibody (MAb) was produced against the capsular polysaccharide (CP) of Neisseria meningitidis serogroup X (MenX) in order to develop a sandwich enzyme linked immunosorbent assay (ELISA) for the quantitation of the meningococcal polysaccharide. The MAb only reacted with the CP from MenX and did not react with CPs from N. meningitidis serogroups A, C, Y and W (MenA, MenC, MenY, MenW). The affinity constant (Ka) of the MAb measured by non-competitive ELISA was 7.25 × 107 M−1. The application of this MAb in a sandwich ELISA was demonstrated by its ability to properly quantitate three lots of an experimental meningococcal CP-based vaccine. The MAb obtained in this work could be a valuable reagent for the detection and quantitation of future meningococcal vaccines containing MenX CP.
Original languageEnglish
Pages (from-to)312-315
Number of pages4
JournalBiologicals
Volume42
Issue number6
DOIs
Publication statusPublished - 2014

Keywords

  • monoclonal antibody
  • Neisseria meningitidis serogroup X
  • ELISA
  • quantitation

Fingerprint

Dive into the research topics of 'A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines'. Together they form a unique fingerprint.

Cite this